Manifestations of sensitivity to a medication may occur on the first day of its
use or not until several months later, depending on the medication.
Usually the onset is abrupt, with chills, fever, rash, pruritus, arthralgia,
anorexia, and nausea. Later, there may be jaundice and dark urine & enlarged
and tender liver. When the offending medication is withdrawn, symptoms may
gradually subside.
FULMINANT HEPATIC FAILURE
Is the clinical syndrome of sudden and severely impaired liver function in a
previously healthy person. According to the original and generally accepted
definition, fulminant hepatic failure develops within 8 weeks of the first
symptoms of jaundice.
Three categories are frequently cited: hyperacute, acute, and subacute liver
failure.
FULMINANT HEPATIC FAILURE
Is the clinical syndrome of sudden and severely impaired liver function in a
previously healthy person.
In hyperacute liver failure, the duration of jaundice before the onset of
encephalopathy is 0 to 7 days; in acute liver failure, it is 8 to 28 days; and in
subacute liver failure, it is 28 to 72 days.
The prognosis for fulminant hepatic failure is much worse than for chronic liver
failure. However, in fulminant failure, the hepatic lesion is potentially
reversible, with survival rates of approximately 50% to 85% (depending on
etiology). Those who do not survive die of massive hepatocellular injury and
necrosis
FULMINANT HEPATIC FAILURE
Fulminant hepatic failure is often accompanied by coagulation defects, renal
failure and electrolyte disturbances, infection, hypoglycemia, encephalopathy,
and cerebral edema.
Viral hepatitis is a common cause of fulminant hepatic failure; other causes:
toxic medications (eg, acetaminophen) and chemicals (eg, carbon tetrachloride),
metabolic disturbances (eg, Wilson's disease, a hereditary syndrome with
deposition of copper in the liver), and structural changes (eg, Budd-Chiari
syndrome, an obstruction to outflow in major hepatic veins .)